Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Akimoto

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Breast Cancer (Tokyo, Japan)|November 20, 2004
Molecular targets for potentiation of radiation-induced cell killingTetsuo Akimoto
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|June 5, 2002
[Prostate cancer]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Chemoradiation Therapy]Tetsuo Akimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Potentiation of radiation-induced cell killing by histone deacetylase inhibitor]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 18, 2008
[Radiobiological basis for hyperfractionated radiation therapy]Tetsuo Akimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Molecular basis and clinical results of radiation therapy combined with molecular targeted therapy]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction]Seiji Niho, Atsushi Motegi, Tetsuo Akimoto
Japanese Journal of Clinical Oncology|November 27, 2014
Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancerYaichiro Hashimoto, Tetsuo Akimoto, Jumpei Iizuka, et al.
Cancer Letters|December 4, 2003
Changes in the number of HSF1 positive granules in the nucleus reflects heat shock semiquantitativelyTetsuo Nonaka, Tetsuo Akimoto, Norio Mitsuhashi, et al.
Cancer Letters|March 1, 2003
Caffeine diminishes cytotoxic effects of paclitaxel on a human lung adenocarcinoma cell lineYoshizumi Kitamoto, Hideyuki Sakurai, Norio Mitsuhashi, et al.
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Breast Cancer (Tokyo, Japan)|November 20, 2004
Molecular targets for potentiation of radiation-induced cell killingTetsuo Akimoto
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|June 5, 2002
[Prostate cancer]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Chemoradiation Therapy]Tetsuo Akimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Potentiation of radiation-induced cell killing by histone deacetylase inhibitor]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 18, 2008
[Radiobiological basis for hyperfractionated radiation therapy]Tetsuo Akimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Molecular basis and clinical results of radiation therapy combined with molecular targeted therapy]Tetsuo Akimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction]Seiji Niho, Atsushi Motegi, Tetsuo Akimoto
Japanese Journal of Clinical Oncology|November 27, 2014
Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancerYaichiro Hashimoto, Tetsuo Akimoto, Jumpei Iizuka, et al.
Cancer Letters|December 4, 2003
Changes in the number of HSF1 positive granules in the nucleus reflects heat shock semiquantitativelyTetsuo Nonaka, Tetsuo Akimoto, Norio Mitsuhashi, et al.
Cancer Letters|March 1, 2003
Caffeine diminishes cytotoxic effects of paclitaxel on a human lung adenocarcinoma cell lineYoshizumi Kitamoto, Hideyuki Sakurai, Norio Mitsuhashi, et al.
Pageof 21